Furthermore, oral exposure to DON significantly up-regulated IL-17 gene expression in back skin tissue compared to the imiquimod control group, indicating that type 3 innate lymphoid cells in the skin, as a source of IL-17, play an important role in the aggravation of psoriasis by DON exposure [11] (Figure 2F). Here, IL17A is linked to psoriasis.